The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease

被引:20
|
作者
Carey, Elizabeth J. [1 ]
Gautam, Manjushree [3 ]
Ingall, Timothy [2 ]
Douglas, David D. [1 ]
机构
[1] Mayo Clin, Div Transplantat Med, Phoenix, AZ 85054 USA
[2] Mayo Clin, Div Neurol, Phoenix, AZ 85054 USA
[3] Univ Iowa, Div Gastroenterol & Hepatol, Iowa City, IA 52242 USA
关键词
D O I
10.1002/lt.21350
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Autonomic dysfunction is a recognized complication of end-stage liver disease (ESLD), but there is little information on how liver transplantation (LT) affects this problem. We sought to prospectively evaluate autonomic function in patients with ESLD before and after LT. Autonomic reflex screen (ARS) was performed on 30 patients with ESLD prior to transplantation. A 10-point composite autonomic score (CAS) was calculated from these data. ARS was repeated after LT, and these scores were compared with the pre-LT ARS. Thirty patients (25 male, 5 female) with cirrhosis that were listed for LT were enrolled in the study and underwent ARS prior to LT. The average age was 55.4 +/- 9.1 years. Indications for LT included hepatitis C virus (14), cryptogenic cirrhosis (5), alcoholic cirrhosis (4), and other (7). The mean native Model for End-Stage Liver Disease (MELD) score at ARS was 17.0 +/- 5.0. Prior to LT, 86.7% of patients had evidence of autonomic dysfunction. Mean CAS was 2.7 +/- 2.2. Sudomotor function was disturbed in 66%, parasympathetic function was disturbed in 57%, and adrenergic function was disturbed in 37%. There was no relationship between pre-LT CAS and age, gender, diabetes, etiology of liver disease, or MELD score. Twenty-one patients (17 male, 4 female) had repeat ARS a mean of 9 +/- 6.2 months after LT. The mean native MELD score at the time of ARS testing was 18.1 +/- 4.3. Mean pre-LT CAS in this group was 3.0 +/- 2.4. Pretransplant CAS was not related to age, gender, diabetes, or MELD score. Autonomic dysfunction improved after LT (CAS pre-LT, 3.0, versus CAS post-LT, 1.9, P = 0.02). There was no relationship between post-LT CAS and age, gender, diabetes, etiology of liver disease, immunosuppression, or type of transplant. In conclusion, autonomic dysfunction is common in patients with ESLD, with over 86% having abnormal testing. Sixty-three percent of patients with cirrhosis with autonomic dysfunction show improvement after LT.
引用
下载
收藏
页码:235 / 239
页数:5
相关论文
共 50 条
  • [41] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280
  • [42] Erectile Dysfunction in End-Stage Liver Disease Men
    Huyghe, Eric
    Kamar, Nassim
    Wagner, Fabien
    Capietto, Aude-Helene
    El-Kahwaji, Labib
    Muscari, Fabrice
    Plante, Pierre
    Rostaing, Lionel
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (05): : 1395 - 1401
  • [43] Liver transplantation for end-stage liver disease related to viral hepatitis
    Tisone, G
    Angelico, M
    Vennarecci, G
    Palmieri, G
    Orlando, G
    Iaria, G
    Baiocchi, L
    Casciani, CU
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1843 - 1845
  • [44] Living related liver transplantation for decompensated end-stage liver disease
    Testa, G
    Malaga, M
    Nadalin, S
    Valentin-Gamazo, C
    Frilling, A
    Broelsch, CE
    JOURNAL OF HEPATOLOGY, 2001, 34 : 50 - 50
  • [45] Liver transplantation due to cerebrotendinous xanthomatosis end-stage liver disease
    Shen, Cong-Huan
    Wang, Zheng-Xin
    WORLD JOURNAL OF PEDIATRICS, 2018, 14 (04) : 414 - 415
  • [46] Role of nutrition in liver transplantation for end-stage chronic liver disease
    Stickel, Felix
    Inderbitzin, Daniel
    Candinas, Daniel
    NUTRITION REVIEWS, 2008, 66 (01) : 47 - 54
  • [47] Liver transplantation due to cerebrotendinous xanthomatosis end-stage liver disease
    Cong-Huan Shen
    Zheng-Xin Wang
    World Journal of Pediatrics, 2018, 14 : 414 - 415
  • [48] Integration of Palliative Care in End-Stage Liver Disease and Liver Transplantation
    Potosek, Jamie
    Curry, Michael
    Buss, Mary
    Chittenden, Eva
    JOURNAL OF PALLIATIVE MEDICINE, 2014, 17 (11) : 1271 - 1277
  • [49] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [50] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99